40
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

Application of Thin‐Layer Chromatography to the Investigation of Oscillatory Instability of Selected Profen Enantiomers in Physiological Salt

, , &
Pages 2059-2069 | Received 06 Jul 2005, Accepted 06 Jul 2005, Published online: 07 Feb 2007
 

Abstract

In earlier investigations, we evaluated the performance of thin‐layer chromatography as an analytical tool to study oscillatory instability of selected profens dissolved in 70% ethanol and dichloromethane. In this study, the solvent used to dissolve profens is changed to physiological salt. The purpose was to assess if the selected test profens [i.e., S‐(+)‐ibuprofen, S‐(+)‐naproxen, and R,S‐(±)‐2‐phenylpropionic acid] can undergo oscillatory transenantiomerization if dissolved in physiological salt. It is a commonly known fact that physiological salt is often drip‐infused into the human (or animal) body with the addition of a drug. Therefore, the question arises whether profen drugs dispensed as physiological salt solutions can undergo oscillatory transenantiomerization in this particular medium. The results of our study confirm that such a transformation is in fact possible.

Acknowledgment

The authors wish to thank Merck KGaA (Darmstadt, Germany) for supplying the TLC plates and the sample of S,R‐(±)‐2‐phenylpropionic acid used in our experiments.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.